These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2849677)

  • 1. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
    el-Fakahany EE; Surichamorn W; Amrhein CL; Stenstrom S; Cioffi CL; Richelson E; McKinney M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL; el-Fakahany EE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
    McKinney M; Richelson E
    Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells.
    Lai WS; el-Fakahany EE
    J Pharmacol Exp Ther; 1987 May; 241(2):366-73. PubMed ID: 3033212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.
    Lee NH; Fryer AD; Forray C; el-Fakahany EE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):992-9. PubMed ID: 2557423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function.
    Feigenbaum P; El-Fakahany EE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):134-40. PubMed ID: 3981451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
    Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI
    J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.
    Kukkonen J; Akerman KE
    Biochem Biophys Res Commun; 1992 Dec; 189(2):919-24. PubMed ID: 1472064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
    Masters SB; Quinn MT; Brown JH
    Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors.
    Cioffi CL; el-Fakahany EE
    Biochem Pharmacol; 1989 Jun; 38(11):1827-34. PubMed ID: 2544180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
    Christopoulos A; Pierce TL; Sorman JL; El-Fakahany EE
    Mol Pharmacol; 1998 Jun; 53(6):1120-30. PubMed ID: 9614217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
    Christopoulos A; Parsons AM; El-Fakahany EE
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1220-8. PubMed ID: 10336509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.